Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
IEEE Transactions on Neural Networks and Learning Systems
|
June 6, 2023
Deep Into the Domain Shift: Transfer Learning Through Dependence Regularization
Shumin Ma, Zhiri Yuan, Qi Wu, et al.
Frontiers in Microbiology
|
June 16, 2025
Effects of corn variety in whole-plant corn silage on dry matter intake, average daily gain and gastrointestinal tract bacteria and metabolites in Hu lambs
Jianxin Jiao, Shumin Ma, Ting Jiao, et al.
Journal of Medicinal Chemistry
|
May 2, 2025
PSMA-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer
Xiaolei Meng, Xiaolin Hu, Shan Gao, et al.
Journal of Medicinal Chemistry
|
September 25, 2025
ZJK-807: A Selective PROTAC Degrader of KRAS<sup>G12D</sup> Overcoming Resistance in Pancreatic Cancer
Zhaojuan Liu, Heping Zheng, Yanqing Tian, et al.
Frontiers in Nutrition
|
October 3, 2022
Biochar combined with organic and inorganic fertilizers promoted the rapeseed nutrient uptake and improved the purple soil quality
Ming Liu, Cholidah Linna, Shumin Ma, et al.
Journal of Medicinal Chemistry
|
September 30, 2024
Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate Cancer
Mengjun Ma, Mengyao Li, Chengwei Zhang, et al.
Pain Physician
|
July 25, 2019
Repetitive Transcranial Magnetic Stimulation at Different Frequencies for Postherpetic Neuralgia: A Double-Blind, Sham-Controlled, Randomized Trial
Qian Pei, Baishan Wu, Yuanzhang Tang, et al.
Oxidative Medicine and Cellular Longevity
|
May 20, 2016
The C-ETS2-TFEB Axis Promotes Neuron Survival under Oxidative Stress by Regulating Lysosome Activity
Shumin Ma, Zijun Fang, Wenwen Luo, et al.
Journal of Medicinal Chemistry
|
July 28, 2025
Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC
Yan Lv, Gaoxin Dai, Bowen Zhang, et al.
Journal of Medicinal Chemistry
|
August 9, 2023
Discovery of <b>BWA-522</b>, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer
Bowen Zhang, Chang Liu, Zhenqian Yang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
IEEE Transactions on Neural Networks and Learning Systems
|
June 6, 2023
Deep Into the Domain Shift: Transfer Learning Through Dependence Regularization
Shumin Ma, Zhiri Yuan, Qi Wu, et al.
Frontiers in Microbiology
|
June 16, 2025
Effects of corn variety in whole-plant corn silage on dry matter intake, average daily gain and gastrointestinal tract bacteria and metabolites in Hu lambs
Jianxin Jiao, Shumin Ma, Ting Jiao, et al.
Journal of Medicinal Chemistry
|
May 2, 2025
PSMA-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer
Xiaolei Meng, Xiaolin Hu, Shan Gao, et al.
Journal of Medicinal Chemistry
|
September 25, 2025
ZJK-807: A Selective PROTAC Degrader of KRAS<sup>G12D</sup> Overcoming Resistance in Pancreatic Cancer
Zhaojuan Liu, Heping Zheng, Yanqing Tian, et al.
Frontiers in Nutrition
|
October 3, 2022
Biochar combined with organic and inorganic fertilizers promoted the rapeseed nutrient uptake and improved the purple soil quality
Ming Liu, Cholidah Linna, Shumin Ma, et al.
Journal of Medicinal Chemistry
|
September 30, 2024
Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate Cancer
Mengjun Ma, Mengyao Li, Chengwei Zhang, et al.
Pain Physician
|
July 25, 2019
Repetitive Transcranial Magnetic Stimulation at Different Frequencies for Postherpetic Neuralgia: A Double-Blind, Sham-Controlled, Randomized Trial
Qian Pei, Baishan Wu, Yuanzhang Tang, et al.
Oxidative Medicine and Cellular Longevity
|
May 20, 2016
The C-ETS2-TFEB Axis Promotes Neuron Survival under Oxidative Stress by Regulating Lysosome Activity
Shumin Ma, Zijun Fang, Wenwen Luo, et al.
Journal of Medicinal Chemistry
|
July 28, 2025
Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC
Yan Lv, Gaoxin Dai, Bowen Zhang, et al.
Journal of Medicinal Chemistry
|
August 9, 2023
Discovery of <b>BWA-522</b>, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer
Bowen Zhang, Chang Liu, Zhenqian Yang, et al.
Page
of 5